• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4594883)   Today's Articles (8)   Subscriber (49329)
For: Best M, Neuhauser D, Slavin L. Evaluating Mesmerism, Paris, 1784: the controversy over the blinded placebo controlled trials has not stopped. Qual Saf Health Care 2003;12:232-3. [PMID: 12792017 PMCID: PMC1743715 DOI: 10.1136/qhc.12.3.232] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Number Cited by Other Article(s)
1
Suter WN. Questionable Research Practices: How to Recognize and Avoid Them. HOME HEALTH CARE MANAGEMENT AND PRACTICE 2020. [DOI: 10.1177/1084822320934468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
2
Anand R, Norrie J, Bradley JM, McAuley DF, Clarke M. Fool's gold? Why blinded trials are not always best. BMJ 2020;368:l6228. [PMID: 31964628 DOI: 10.1136/bmj.l6228] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
3
Micoulaud-Franchi JA, Quilès C, Cermolacce M, Belzeaux R, Adida M, Fakra E, Azorin JM. Électroconvulsivothérapie et niveau de preuve : de la causalité à la relation dose-effet. Encephale 2016;42:S51-S59. [DOI: 10.1016/s0013-7006(17)30055-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA